Yili Group Showcases Dairy Innovation and Functional Product Development at the 19th Global Dairy Congress
CAMBRIDGE, England, June 29, 2026 /PRNewswire/ -- From June 17 to 18, the 19th Global Dairy Congress, themed "Fit for Purpose," was held in Barcelona, Spain, bringing together dairy industry leaders and representatives from around the globe. On the opening day, Dr. Ignatius Szeto, Vice President of Yili Group, delivered a keynote speech titled "Creating High Value Functional Product...
TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education
Efforts include support for earlier diagnosis through LAMair™, TrilliumBiO's newly developed VEGF‑D test ROCKVILLE, Md. and CINCINNATI, June 29, 2026 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a commitment to raising awareness of lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women. As...
Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
Deepening Its Commitment to Kidney Disease and Accelerating Toward Becoming a Global Leader in Renal Innovation SHANGHAI, June 29, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a biopharmaceutical company focused on kidney disease, with the broadest pipeline by renal indication coverage, today listed on the Main Board of The Stock Exchange...
Health In Tech Added to Membership of Russell Microcap® Index
STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market opens on June 29, 2026, as part of the 2026 Russell U.S. indexes reconstitution. ...
Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion
TAICHUNG, June 29, 2026 /PRNewswire/ -- Ever Supreme Bio Technology Co., Ltd. (TWSE: 6712) announced on June 28 that CAR001, its proprietarily developed, allogeneic, "off-the-shelf" CAR-T cell therapy for cancer, has successfully cleared review by the Safety Monitoring Committee (SMC). Following a thorough evaluation of the Phase I safety profile and preliminary efficacy data, the committee has greenlit...
MALAYSIA HEALTHCARE CONNECTS CAMBODIAN FAMILIES WITH LEADING MALAYSIAN HOSPITALS DURING FIRST-EVER PHNOM PENH EXPO
PHNOM PENH, Cambodia, June 29, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) today launched the first-ever Malaysia Healthcare Expo (MHX) Phnom Penh, marking the first MHX to be held in Cambodia and the organisation's first consumer-focused healthcare expo outside Indonesia. Cambodia rapidly emerges as an increasingly important growth market for Malaysia Healthcare. Healthcare traveller volume from Cambodia...
International Health Innovation & Exchange Association (IHIEA) Launches in Hong Kong and Unveils Six-Point Action Blueprint
Focusing on cross-border healthcare, continuing medical education, innovation translation, Global Medical Excellence Center certification, data collaboration and standards for emerging technologies HONG KONG, June 29, 2026 /PRNewswire/ -- The International Health Innovation & Exchange Association (IHIEA) held its launch press conference in Hong Kong today, formally announcing the platform's establishment and unveiling its future-oriented Six-Point Action Blueprint. Based in...
4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia
Non-contrast, ventilation-perfusion imaging—from routine chest CT scans MELBOURNE, Australia, June 29, 2026 /PRNewswire/ -- 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has Therapeutic Goods Administration (TGA) approval and is included on the Australian Register of Therapeutic Goods (ARTG)—enabling commercial deployment across Australia....
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 29, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today announced the appointment of Dr. Lloyd Klickstein as Scientific Advisor for Immunology....
Sisram Medical’s China Manufacturing Facility Commences Operations as First Locally Produced Alma Rejuve Rolls Off the Line
Localization strategy advances with strengthened end-to-end capabilities across R&D, manufacturing and commercialization HONG KONG, June 29, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced that its China manufacturing facility in Miyun, Beijing has commenced operations, with the first locally produced...
